APPL1
Basic information
Region (hg38): 3:57227726-57278105
Links
Phenotypes
GenCC
Source:
- maturity-onset diabetes of the young type 14 (Strong), mode of inheritance: AD
- maturity-onset diabetes of the young (Supportive), mode of inheritance: AD
- maturity-onset diabetes of the young type 14 (Limited), mode of inheritance: Unknown
- monogenic diabetes (Limited), mode of inheritance: AD
- maturity-onset diabetes of the young type 14 (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Maturity-onset diabetes of the young, type 14 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Endocrine | 26073777 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (129 variants)
- not_specified (77 variants)
- Maturity-onset_diabetes_of_the_young_type_14 (15 variants)
- APPL1-related_disorder (14 variants)
- Monogenic_diabetes (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the APPL1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000012096.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 22 | 28 | ||||
missense | 102 | 11 | 114 | |||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 2 | 1 | 107 | 34 | 3 |
Highest pathogenic variant AF is 0.00000343399
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
APPL1 | protein_coding | protein_coding | ENST00000288266 | 22 | 45732 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.795 | 0.205 | 125627 | 0 | 121 | 125748 | 0.000481 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.716 | 329 | 368 | 0.895 | 0.0000193 | 4655 |
Missense in Polyphen | 107 | 117.12 | 0.91356 | 1398 | ||
Synonymous | 0.880 | 108 | 120 | 0.898 | 0.00000583 | 1284 |
Loss of Function | 4.96 | 9 | 44.9 | 0.201 | 0.00000240 | 561 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000835 | 0.000808 |
Ashkenazi Jewish | 0.000103 | 0.0000992 |
East Asian | 0.000227 | 0.000217 |
Finnish | 0.000199 | 0.000185 |
European (Non-Finnish) | 0.000763 | 0.000712 |
Middle Eastern | 0.000227 | 0.000217 |
South Asian | 0.000398 | 0.000392 |
Other | 0.000510 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Adapter protein that interacts with proteins involved in different cellular signaling pathways. Required for the regulation of cell proliferation in response to extracellular signals from an early endosomal compartment. Links Rab5 to nuclear signal transduction. Involved in the regulation of the insulin receptor signaling pathway. {ECO:0000269|PubMed:10490823, ECO:0000269|PubMed:15016378, ECO:0000269|PubMed:26073777}.;
- Disease
- DISEASE: Maturity-onset diabetes of the young 14 (MODY14) [MIM:616511]: A form of diabetes that is characterized by an autosomal dominant mode of inheritance, onset in childhood or early adulthood (usually before 25 years of age), a primary defect in insulin secretion and frequent insulin-independence at the beginning of the disease. {ECO:0000269|PubMed:26073777}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Longevity regulating pathway - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Colorectal cancer - Homo sapiens (human);Follicle Stimulating Hormone (FSH) signaling pathway;Chromosomal and microsatellite instability in colorectal cancer;Caspase activation via extrinsic apoptotic signalling pathway;Apoptosis;Programmed Cell Death;AndrogenReceptor;EGFR1;Coregulation of Androgen receptor activity;Ligand-independent caspase activation via DCC;FSH
(Consensus)
Intolerance Scores
- loftool
- 0.838
- rvis_EVS
- 0.04
- rvis_percentile_EVS
- 57.41
Haploinsufficiency Scores
- pHI
- 0.342
- hipred
- Y
- hipred_score
- 0.651
- ghis
- 0.613
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.925
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Appl1
- Phenotype
- muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- appl1
- Affected structure
- whole organism
- Phenotype tag
- abnormal
- Phenotype quality
- edematous
Gene ontology
- Biological process
- cell cycle;signal transduction;cell population proliferation;insulin receptor signaling pathway;signaling;regulation of glucose import;extrinsic apoptotic signaling pathway in absence of ligand;regulation of protein localization to plasma membrane
- Cellular component
- nucleus;early endosome;cytosol;endosome membrane;vesicle membrane;early endosome membrane;extracellular exosome
- Molecular function
- protein binding;identical protein binding;protein kinase B binding;protein-containing complex binding